GLS and rheumatic fever: Clinically this has been observed with acute rheumatic fever (ARF) patients having 2- to 3- fold higher anti-GAC antibody titres at the point of infection compared to patients with pharyngitis28, as well as longer lived anti-GAC antibody populations in patients which have rheumatic heart disease (RHD)29.